Article
Association of complement factor H and LOC387715 genotypes with response of exudative age-related macular degeneration to intravitreal bevacizumab.
Ophthalmology - 1 Dec 2007
Brantley Milam A, Fang Amy M, King Jennifer M, Tewari Asheesh, Kymes Steven M, Shiels Alan
Abstract excerpt
PURPOSE: To investigate whether there is an association between complement factor H (CFH) or LOC387715 genotypes with response to treatment with intravitreal bevacizumab for exudative age-related macular degeneration (AMD). DESIGN: Retrospective cohort study. PARTICIPANTS: The study cohort consisted of 86 patients being treated for neovascular AMD with bevacizumab alone. METHODS: Genotype determination for the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
